Tagged with P

Mexico David López García, Mexico country manager of global rare genetic therapy player Biomarin, outlines the challenging situation around patient access to orphan drugs in Mexico and the importance of building awareness of rare diseases.   The challenge for orphan drugs is the price. It is not always easy to explain…

Czech Republic Olga Starobová, medical director of Syneos Health Czech Republic, walks us through the steps put in place to ensure successful synergies during the merger between INC Research and InVentiv Health, which has created a unique company with both clinical and commercial operations under one roof. Starobová talks about her views…

Morocco Layla Sentissi, executive director of AMIP, Morocco’s oldest pharma association, explains the structure of the country’s pharmaceutical industry and its key developments, lays down her ambition to create a National Pact for Medicines, discusses the key challenges for the local industry, and invites global decision-makers of to the Africa Health…

China 2019 was a landmark year for the Chinese healthcare industry.* Since the publication of the ‘Healthy China 2030’ blueprint in 2016 by the Chinese government, the entire sector has been virtually turned upside down. Against the warm backdrop of regulatory support, a series of policy changes were unveiled in the…

Belgium The top 20 pharma companies in Belgium ranked by revenue for the financial year 2019. EG Generics is way out in front with EUR 210 million in revenue, followed by Novartis Pharma and Janssen-Cilag.   Made with Visme Infographic Maker   The top 20 pharma companies in Belgium ranked by…

Romania Highlighting the top 50 pharma companies in Romania by value for the year ending December 2019. Multinationals MSD, Sanofi and Novartis top the list, but regional players such as Romanian firm Antibiotice, Slovenian Krka and Czech-headquartered  Zentiva are also represented.    Made with Visme Infographic Maker

Romania Pascal Robin, country chair of Sanofi and general manager of Sanofi Pasteur for Romania and Moldova, shares his insights on the intrinsic and extrinsic factors that helped Sanofi become a market leader in Romania. He reveals how the affiliate’s well-diversified portfolio is adapted to Romanian needs and how it is…

Japan In April 2019, Yasuhiro Fujiwara was appointed as the new chief executive of Japan’s drug regulator and one of the world’s foremost regulatory bodies, the Pharmaceuticals and Medical Devices Agency (PMDA). Upon appointment, Fujiwara coined the “Four Fs” strategy, urging PMDA employees to have a “patient first,” “access first,” “safety…

Czech Republic Kostas Deligiannis, general manager Eastern Europe for GE Healthcare (GEHC), outlines GE Healthcare’s commitment to the 20-country region under his remit, his priorities for greater collaboration between these countries, and how GE Healthcare’s innovations continue to set the bar high for both long term cost savings and improvements to patients’…

Global To celebrate International Women’s Day 2020, PharmaBoardroom brings you insights from some of the most inspirational female industry leaders we have had the privilege of talking to over the past 12 months.   Janet Woodcock, Director, Center for Drug Evaluation and Research (CDER), US FDA     Science really can…

Europe EFPIA’s Nathalie Moll highlights how Europe can reverse its decline in the global medical research standings and once again make the continent a world leader in medical innovation.   If the content of the Pharmaceutical Strategy undermines the ambition of the Industrial Strategy then there is a very real, immediate…

UAE With a combined experience of over five decades in the pharmaceutical industry including senior executive roles at companies such as Merck and Janssen, Karim Smaira and Kamel Ghammachi have come a long way with Genpharm, the Dubai-based market access company they founded in 2012. After years of learning the ins…